Citius Pharmaceuticals, Inc. (CTXR) Net margin 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) net profit margin by fiscal year — reported net income divided by reported revenue.
-37378.5%FY2022 · since FY2017: -20769.9% → -37378.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -37378.5% | -11762.5 pp |
| FY2021 | -25616.0% | -6118.2 pp |
| FY2020 | -19497.9% | -2206.6 pp |
| FY2019 | -17291.3% | -575.8 pp |
| FY2018 | -16715.5% | +4054.4 pp |
| FY2017 | -20769.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →